RIGImmune Inc.
PrivateLast Round
Series A
Apr 1, 2024
Est. Valuation
$18.25M
Total Funding Raised
$15M
Company Overview
RIGImmune Inc. is a biopharmaceutical company developing a new class of RNA immunotherapeutics that selectively activate the innate immune sensor RIG-I to treat diseases caused by RNA viruses and to induce antitumor immune responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RIGImmune Inc. Comparables
Compare RIGImmune Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 77% | |
| Xanadu Bio | 77% | |
| NorthLinks Bio | 76% |
RIGImmune Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2024 | ||||
| Grant | Dec 7, 2022 | ||||
| VC Round | Dec 7, 2022 | ||||
| VC Round | Sep 15, 2022 | ||||
| Seed | Dec 10, 2021 |
Key People
Founding team and executive leadership
RIGImmune Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rivermount Ventures | VC Round |
| Bill & Melinda Gates Foundation | VC Round, Grant |
| Yale Ventures | Seed |
| F-Prime Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 219% MoM.
- Apr 1, 2024
Completed a Series A funding round.
RIGImmune Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RIGImmune Inc.'s valuation, stock price, and market status.
Is RIGImmune Inc. a public or private company?
RIGImmune Inc. is a private company.
What is the current stock price of RIGImmune Inc.?
RIGImmune Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is RIGImmune Inc. worth (valuation)?
Valuation information for RIGImmune Inc. is not publicly available.
Can I buy RIGImmune Inc. stock?
RIGImmune Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RIGImmune Inc.'s last funding round?
Funding round information for RIGImmune Inc. is not publicly available.
Who are the main investors in RIGImmune Inc.?
Investor information for RIGImmune Inc. is not publicly disclosed.
Will RIGImmune Inc. IPO soon?
No public IPO plans have been announced for RIGImmune Inc..
How can I track RIGImmune Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RIGImmune Inc.'s secondary market activity and sign up for updates.